Cargando…

Impact of mechanical circulatory support and immunomodulation therapy on outcome of patients with fulminant myocarditis: Chinese registry of fulminant myocarditis

Detalles Bibliográficos
Autores principales:	Zhou, Ning, Zhao, Yuhua, Jiang, Jiangang, Shen, Lan, Li, Junming, Wan, Jing, Ma, Xueping, Zhang, Jing, Ammirati, Enrico, Wang, Dao Wen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8492670/ https://www.ncbi.nlm.nih.gov/pubmed/34611131 http://dx.doi.org/10.1038/s41392-021-00700-6

Ejemplares similares

Fulminant myocarditis: Characteristics, treatment, and outcomes
por: Veronese, Giacomo, et al.
Publicado: (2018)

Mechanical Circulatory Support as a Bridge to Recovery in Fulminant Myocarditis
por: Iqbal, Yassir, et al.
Publicado: (2015)

New concepts in fulminant myocarditis and risk of cardiac mortality
por: Ammirati, Enrico, et al.
Publicado: (2017)

Successive immunosuppressive treatment of fulminant myocarditis that is refractory to mechanical circulatory support
por: Nakashima, Hiroshi, et al.
Publicado: (2013)

Fulminant myocarditis in adults: a narrative review
por: Montero, Santiago, et al.
Publicado: (2022)

COVID-19 “Fulminant Myocarditis” Successfully Treated With Temporary Mechanical Circulatory Support
por: Salamanca, Jorge, et al.
Publicado: (2020)

Early characteristics of fulminant myocarditis vs non-fulminant myocarditis: A meta-analysis
por: Wang, Zicheng, et al.
Publicado: (2019)

Characteristics of Electrocardiogram Findings in Fulminant Myocarditis
por: Dai, Mei-Yan, et al.
Publicado: (2023)

Fulminant Giant Cell Myocarditis Requiring Bridge With Mechanical Circulatory Support to Heart Transplantation
por: Brailovsky, Yevgeniy, et al.
Publicado: (2022)

When should mechanical circulatory support be considered in pediatric patients with acute fulminant myocarditis?
por: Kwon, Hye Won
Publicado: (2020)

Fulminant versus non fulminant acute myocarditis: evolution of functional parameters evaluated with cardiac magnetic resonance
por: Pedrotti, Patrizia, et al.
Publicado: (2016)

Fulminant myocarditis in the time of coronavirus
por: Cuomo, Vittoria, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19
por: Joob, Beuy, et al.
Publicado: (2020)

COVID-Induced Fulminant Myocarditis
por: Rodriguez Guerra, Miguel A, et al.
Publicado: (2022)

A case of COVID‐19‐associated fulminant myocarditis successfully treated with mechanical circulatory support
por: Asakura, Ryosuke, et al.
Publicado: (2022)

Fulminant necrotizing eosinophilic myocarditis after COVID‐19 vaccination survived with mechanical circulatory support
por: Kimura, Mitsukuni, et al.
Publicado: (2022)

Successful rescue of fulminant myocarditis with mechanical circulatory support and immunosuppression therapy: A case report
por: Zhou, Chi
Publicado: (2023)

Transient Myocarditis Associated with Fulminant Colitis
por: Williamson, J. M. L., et al.
Publicado: (2011)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Consideration on pathogen of viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Fulminant myocarditis and COVID-19. Response
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant myocarditis due to COVID-19
por: Irabien-Ortiz, Ángela, et al.
Publicado: (2020)

Fulminant Eosinophilic Myocarditis and VT Storm
por: Hoppens, Kyle R., et al.
Publicado: (2021)

Tozinameran: Fulminant myocarditis: case report
Publicado: (2022)

Anakinra in pediatric acute fulminant myocarditis
por: Maunier, Louise, et al.
Publicado: (2022)

Influenza A (H3N2) Induced Fulminant Myocarditis Requiring Mechanical Circulatory Support
por: Hollowed, John, et al.
Publicado: (2019)

Enterovirus fulminant myocarditis as cause of acute heart failure in a newborn
por: Annoni, Giuseppe, et al.
Publicado: (2022)

Fulminant myocarditis in a COVID-19 positive patient treated with mechanical circulatory support – a case report
por: Papageorgiou, Joanna-Maria, et al.
Publicado: (2020)

Biopsy-Proven Fulminant Myocarditis Requiring Mechanical Circulatory Support Following COVID-19 mRNA Vaccination
por: Kazama, Shingo, et al.
Publicado: (2022)

Case Report: COVID-19 Vaccination Associated Fulminant Myocarditis
por: Cui, Guanglin, et al.
Publicado: (2022)

Mode-of-action of the PROPELLA concept in fulminant myocarditis
por: Spillmann, Frank, et al.
Publicado: (2019)

Parvovirus B19 Myocarditis of Fulminant Evolution
por: Spartalis, Michael, et al.
Publicado: (2017)

Fulminant myocarditis with myositis of ocular and respiratory muscles
por: Hiraiwa, Hiroaki, et al.
Publicado: (2020)

Glucocorticoid and immunoglobulin to treat viral fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

SARS-CoV-2 Fulminant Myocarditis
por: Garot, Jérôme, et al.
Publicado: (2020)

Immune-mediated mechanism in coronavirus fulminant myocarditis
por: Wei, Xin, et al.
Publicado: (2020)

Azd-1222: Fulminant myocarditis: case report
Publicado: (2022)

Fulminant Bacterial Myocarditis Presenting as Myocardial Infarction
por: Trpkov, Cvetan, et al.
Publicado: (2020)

Clinical and electrocardiographic characteristics in patients with fulminant myocarditis
por: Itoh, Tomonori, et al.
Publicado: (2022)

Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis
por: Wang, Jin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_osmv2c0jfrvmqmgjhakcfvu035